Harrow Health is trading 5.34% down at $27.21, with no clear catalyst identified for the October 16 decline.
- Available market coverage detected no new macro, sector, or company-specific catalyst. Healthcare was higher, so sector weakness does not explain the move.
- Shares touched a 52-week intraday low of $26.96. The earlier quarterly earnings miss is background, not a confirmed trigger for this session’s decline.